Logo image
Se connecter
Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy
Article de revue   Avec comité de lecture

Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy

Marco Valgimigli, Enrico Frigoli, Pascal Vranckx, Yukio Ozaki, Marie-Claude Morice, Bernard Chevalier, Yoshinobu Onuma, Stephan Windecker, Laurent Delorme, Petr Kala, …
Journal of the American College of Cardiology, Vol.80, pp.766-778
01/08/2022

Résumé

acetylsalicylic acid Combination Drug Therapy drug-eluting stent Drug-Eluting Stents/adverse effects dual antiplatelet therapy Hemorrhage/chemically induced high bleeding risk Humans Medication Adherence P2Y inhibitor acetylsalicylic acid drug-eluting stent dual antiplatelet therapy high bleeding risk P2Y12 inhibitor Percutaneous Coronary Intervention/methods Platelet Aggregation Inhibitors/therapeutic use Polymers Treatment Outcome

Indicateurs

1 Consultations de la notice

Détails

Logo image